Carcinoma della prostata: prostatectomia radicale nei pazienti over 70

Massimo Madonia, Paolo Soggia, Gianmarco Garau, Sebastiano Cimino, Giuseppe Morgia, Carlo Corbu

DOI: https://doi.org/10.7175/rhc.v4i2.652

Abstract

Prostate cancer is one of the most common male cancers in industrialized countries and it occurs mainly in men older than 50 years. In light of a rapidly ageing population it seems certain tha increasingly many septuagenarians with significant life-expectancy will present with prostate cancer to urologist. However currently there is a lack of consensus on prostate cancer and its treatment in the cohort of men ≥ 70 years of age. Although elderly men are often recommended a watchfull waiting option based on lower life expentancy and potentially slow disease progression, recent evidences indicate suggest a potential benefit of radical prostatectomy in selected older patients. The aim of this review is to illustrate the evidences demonstrating the efficacy and safety and of radical prostatectomy in patients over 70. Also, are presented the results of a small Italian study on patients aged ≥ 70 years with clinically localized prostate cancer undergoing radical prostatectomy. The results show that radical prostatectomy is a safe and effective option in elderly patients, with low incidence of complications and recovery of continence in about two-thirds of patients.

Keywords

Radical prostatectomy; Prostate cancer; Elderly men

Full Text

HTML PDF

References

  • Inghelmann R, Grande E, Francisci S, et al. Regional estimates of prostate cancer burden in Italy. Tumori 2007; 93: 380-6; http://dx.doi.org/10.1700/294.3481
  • AIOM-AIRTUM. I numeri del cancro in Italia, 2012. Brescia: Intermedia, 2012
  • I.Stat. Previsioni demografiche - Anni 2011-2065: Indicatori demografici. Disponibile su: http://dati.istat.it
  • AIRTUM Working Group. I tumori in Italia – Rapporto 2011. La sopravvivenza dei pazienti oncologici in Italia. Epidemiol Prev 2011; 35 (suppl 3): 1-200
  • Gatta G, Zigon G, Buemi A, et al. Prostate cancer treatment in Europe at the end of 1990s. Acta Oncol 2009; 48: 867-73; http://dx.doi.org/10.1080/02841860902719174
  • Linee guida AIOM. Carcinoma della prostata. 2012
  • Consiglio Nazionale delle Ricerche. Ministero della’Istruzione dell’Università e della Ricerca. Basi scientifiche per linee guida – Prostata. Disponibile su www.progettooncologia.cnr.it
  • Heidenreich A, Bastian PJ, Bellmunt J, et al. Guidelines on Prostate Cancer. European Association of Urology, 2012
  • Sobin LH, Gospodariwicz M, Wittekind C (eds). TNM classification of malignant tumors. UICC International Union Against Cancer. 7th edn. Wiley-Blackwell, 2009; pp. 243-248
  • Treiyer A, Anheuser P, Bütow Z, et al. A single center prospective study: prediction of postoperative general quality of life, potency and continence after radical retropubic prostatectomy. J Urol 2011; 185: 1681-5; http://dx.doi.org/10.1016/j.juro.2010.12.052
  • Eifler JB, Humphreys EB, Agro M, et al. Causes of death after radical prostatectomy at a large tertiary center. J Urol 2012; 188: 798-801; http://dx.doi.org/10.1016/j.juro.2012.04.109
  • Bill-Axelson A, Holmberg L, Ruutu M, et al.; SPCG-4 Investigators. Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med 2011; 364: 1708-17; http://dx.doi.org/10.1056/NEJMoa1011967
  • Richstone L, Bianco FJ, Shah HH, et al. Radical prostatectomy in men aged >or=70 years: effect of age on upgrading, upstaging, and the accuracy of a preoperative nomogram. BJU Int 2008; 101: 541-6; http://dx.doi.org/10.1111/j.1464-410X.2007.07410.x
  • Kunz I, Musch M, Roggenbuck U, et al. Tumour characteristics, oncological and functional outcomes in patients aged ≥ 70 years undergoing radical prostatectomy. BJU Int 2013; 111: E24-9; http://dx.doi.org/ 10.1111/j.1464-410X.2012.11368.x
  • Konety BR, Cowan JE, Carroll PR; CaPSURE Investigators. Patterns of primary and secondary therapy for prostate cancer in elderly men: analysis of data from CaPSURE. J Urol 2008; 179: 1797-803; http://dx.doi.org/10.1016/j.juro.2008.01.044
  • Yan Y, Carvalhal GF, Catalona WJ, et al: Primary treatment choices for men with clinically localized prostate carcinoma detected by screening. Cancer 2000; 88: 1122-30
  • D’Amico AV, Cote K, Loffredo M, et al. Advanced age at diagnosis is an independent predictor of time to death from prostate carcinoma for patients undergoing external beam radiation therapy for clinically localized prostate carcinoma. Cancer 2003; 97: 56-62; http://dx.doi.org/10.1002/cncr.11053
  • Schwartz KL, Alibhai SM, Tomlinson G, et al. Continued undertreatment of older men with localized prostate cancer. Urology 2003; 62: 860-5
  • Delongchamps NB, Wang CY, Chandan V, et al. Pathological characteristics of prostate cancer in elderly men. J Urol 2009; 182: 927-30; http://dx.doi.org/10.1016/j.juro.2009.05.018
  • Brassell SA, Rice KR, Parker PM, et al. Prostate cancer in men 70 years old or older, indolent or aggressive: clinicopathological analysis and outcomes. J Urol 2011; 185: 132-7; http://dx.doi.org/10.1016/j.juro.2010.09.014
  • Alibhai SM, Naglie G, Nam R, et al. Do older men benefit from curative therapy of localized prostate cancer? J Clin Oncol 2003; 21: 3318-27
  • Grossfeld GD, Chang JJ, Broering JM, et al. Under staging and under grading in a contemporary series of patients undergoing radical prostatectomy: results from the Cancer of the Prostate Strategic Urologic Research Endeavor database. J Urol 2001; 165: 851-6

Statistics

Abstract: 1237 views
HTML: 55608 views
PDF: 270 views

Refbacks

  • There are currently no refbacks.




© SEEd srl